AAPL305.70+11.32 (+3.85%) ▲|ABBV258.05+6.99 (+2.78%) ▲|ABT94.76+2.58 (+2.80%) ▲|ACN135.97+4.84 (+3.69%) ▲|ADBE217.81+6.83 (+3.24%) ▲|AMAT602.54-48.37 (-7.43%) ▼|AMD522.02-18.86 (-3.49%) ▼|AMGN372.01+10.68 (+2.96%) ▲|AMT165.97-0.11 (-0.07%) ▼|AMZN244.89+3.19 (+1.32%) ▲|AVGO364.43-4.91 (-1.33%) ▼|AXP348.71+1.66 (+0.48%) ▲|BA224.75+6.17 (+2.82%) ▲|BAC58.56+0.20 (+0.33%) ▲|BKNG184.57+1.93 (+1.06%) ▲|BLK987.88+7.50 (+0.76%) ▲|BMY57.47+1.66 (+2.97%) ▲|BNY145.77-0.25 (-0.17%) ▼|BRK-B506.07+6.33 (+1.27%) ▲|C139.61-0.52 (-0.37%) ▼|CAT970.91-20.50 (-2.07%) ▼|CL94.61+1.85 (+1.99%) ▲|CMCSA23.18-0.56 (-2.34%) ▼|COF204.85+0.03 (+0.01%) ▲|COP103.81+0.59 (+0.57%) ▲|COST942.73+18.06 (+1.95%) ▲|CRM165.66+2.43 (+1.49%) ▲|CSCO112.46-4.55 (-3.89%) ▼|CVS104.35-0.46 (-0.44%) ▼|CVX167.96+2.27 (+1.37%) ▲|DE628.06+0.43 (+0.07%) ▲|DHR197.42+3.70 (+1.91%) ▲|DIS97.36+1.65 (+1.72%) ▲|DUK127.41+1.64 (+1.30%) ▲|EMR139.63+0.11 (+0.08%) ▲|FDX314.94+1.05 (+0.33%) ▲|GD369.46+8.19 (+2.27%) ▲|GE377.77+2.83 (+0.75%) ▲|GEV1,105.85-28.51 (-2.51%) ▼|GILD130.24+4.27 (+3.39%) ▲|GM74.95-0.57 (-0.75%) ▼|GOOG352.60-5.29 (-1.48%) ▼|GOOGL355.93-5.28 (-1.46%) ▼|GS1,020.55+0.94 (+0.09%) ▲|HD355.60+4.76 (+1.36%) ▲|HON221.84+0.09 (+0.04%) ▲|IBM286.00-0.25 (-0.09%) ▼|INTC123.42-3.60 (-2.83%) ▼|INTU272.14+5.06 (+1.89%) ▲|ISRG420.33+17.95 (+4.46%) ▲|JNJ260.40+6.42 (+2.53%) ▲|JPM333.45-0.63 (-0.19%) ▼|KO83.10+1.81 (+2.23%) ▲|LIN545.71+12.16 (+2.28%) ▲|LLY1,213.79+22.05 (+1.85%) ▲|LMT538.10+16.28 (+3.12%) ▲|LOW226.35+4.43 (+2.00%) ▲|LRCX362.86-28.41 (-7.26%) ▼|MA534.61+12.17 (+2.33%) ▲|MCD275.85+6.42 (+2.38%) ▲|MDLZ60.16+0.81 (+1.36%) ▲|MDT81.96+2.76 (+3.48%) ▲|META587.83-25.08 (-4.09%) ▼|MMM160.21+0.25 (+0.16%) ▲|MO72.42+0.88 (+1.22%) ▲|MRK128.35+2.98 (+2.38%) ▲|MS212.81+0.95 (+0.45%) ▲|MSFT388.67+4.39 (+1.14%) ▲|MU994.02-38.26 (-3.71%) ▼|NEE87.08+0.71 (+0.82%) ▲|NFLX76.92+2.73 (+3.68%) ▲|NKE44.11+1.05 (+2.44%) ▲|NOW105.02-0.79 (-0.74%) ▼|NVDA194.46-3.12 (-1.58%) ▼|ORCL140.65-1.85 (-1.30%) ▼|PEP143.17+2.01 (+1.42%) ▲|PFE24.29+0.41 (+1.70%) ▲|PG150.62+3.19 (+2.16%) ▲|PLTR129.26+3.53 (+2.80%) ▲|PM180.70+3.01 (+1.69%) ▲|QCOM175.41-6.51 (-3.58%) ▼|RTX196.78+5.00 (+2.61%) ▲|SBUX105.31+1.92 (+1.86%) ▲|SCHW96.53+0.75 (+0.78%) ▲|SO96.50+1.38 (+1.45%) ▲|SPG224.55+1.55 (+0.69%) ▲|T20.05-0.44 (-2.12%) ▼|TMO526.53+13.20 (+2.57%) ▲|TMUS173.95+0.89 (+0.51%) ▲|TSLA399.63-25.67 (-6.04%) ▼|TXN294.77-3.64 (-1.22%) ▼|UBER73.75+1.09 (+1.50%) ▲|UNH428.35+1.81 (+0.42%) ▲|UNP280.80+3.07 (+1.11%) ▲|UPS110.40+0.86 (+0.79%) ▲|USB61.55-0.41 (-0.66%) ▼|V358.60+7.52 (+2.14%) ▲|VZ41.09-0.91 (-2.16%) ▼|WFC85.50-0.44 (-0.51%) ▼|WMT111.52+2.70 (+2.48%) ▲|XOM136.84+0.56 (+0.41%) ▲|AAPL305.70+11.32 (+3.85%) ▲|ABBV258.05+6.99 (+2.78%) ▲|ABT94.76+2.58 (+2.80%) ▲|ACN135.97+4.84 (+3.69%) ▲|ADBE217.81+6.83 (+3.24%) ▲|AMAT602.54-48.37 (-7.43%) ▼|AMD522.02-18.86 (-3.49%) ▼|AMGN372.01+10.68 (+2.96%) ▲|AMT165.97-0.11 (-0.07%) ▼|AMZN244.89+3.19 (+1.32%) ▲|AVGO364.43-4.91 (-1.33%) ▼|AXP348.71+1.66 (+0.48%) ▲|BA224.75+6.17 (+2.82%) ▲|BAC58.56+0.20 (+0.33%) ▲|BKNG184.57+1.93 (+1.06%) ▲|BLK987.88+7.50 (+0.76%) ▲|BMY57.47+1.66 (+2.97%) ▲|BNY145.77-0.25 (-0.17%) ▼|BRK-B506.07+6.33 (+1.27%) ▲|C139.61-0.52 (-0.37%) ▼|CAT970.91-20.50 (-2.07%) ▼|CL94.61+1.85 (+1.99%) ▲|CMCSA23.18-0.56 (-2.34%) ▼|COF204.85+0.03 (+0.01%) ▲|COP103.81+0.59 (+0.57%) ▲|COST942.73+18.06 (+1.95%) ▲|CRM165.66+2.43 (+1.49%) ▲|CSCO112.46-4.55 (-3.89%) ▼|CVS104.35-0.46 (-0.44%) ▼|CVX167.96+2.27 (+1.37%) ▲|DE628.06+0.43 (+0.07%) ▲|DHR197.42+3.70 (+1.91%) ▲|DIS97.36+1.65 (+1.72%) ▲|DUK127.41+1.64 (+1.30%) ▲|EMR139.63+0.11 (+0.08%) ▲|FDX314.94+1.05 (+0.33%) ▲|GD369.46+8.19 (+2.27%) ▲|GE377.77+2.83 (+0.75%) ▲|GEV1,105.85-28.51 (-2.51%) ▼|GILD130.24+4.27 (+3.39%) ▲|GM74.95-0.57 (-0.75%) ▼|GOOG352.60-5.29 (-1.48%) ▼|GOOGL355.93-5.28 (-1.46%) ▼|GS1,020.55+0.94 (+0.09%) ▲|HD355.60+4.76 (+1.36%) ▲|HON221.84+0.09 (+0.04%) ▲|IBM286.00-0.25 (-0.09%) ▼|INTC123.42-3.60 (-2.83%) ▼|INTU272.14+5.06 (+1.89%) ▲|ISRG420.33+17.95 (+4.46%) ▲|JNJ260.40+6.42 (+2.53%) ▲|JPM333.45-0.63 (-0.19%) ▼|KO83.10+1.81 (+2.23%) ▲|LIN545.71+12.16 (+2.28%) ▲|LLY1,213.79+22.05 (+1.85%) ▲|LMT538.10+16.28 (+3.12%) ▲|LOW226.35+4.43 (+2.00%) ▲|LRCX362.86-28.41 (-7.26%) ▼|MA534.61+12.17 (+2.33%) ▲|MCD275.85+6.42 (+2.38%) ▲|MDLZ60.16+0.81 (+1.36%) ▲|MDT81.96+2.76 (+3.48%) ▲|META587.83-25.08 (-4.09%) ▼|MMM160.21+0.25 (+0.16%) ▲|MO72.42+0.88 (+1.22%) ▲|MRK128.35+2.98 (+2.38%) ▲|MS212.81+0.95 (+0.45%) ▲|MSFT388.67+4.39 (+1.14%) ▲|MU994.02-38.26 (-3.71%) ▼|NEE87.08+0.71 (+0.82%) ▲|NFLX76.92+2.73 (+3.68%) ▲|NKE44.11+1.05 (+2.44%) ▲|NOW105.02-0.79 (-0.74%) ▼|NVDA194.46-3.12 (-1.58%) ▼|ORCL140.65-1.85 (-1.30%) ▼|PEP143.17+2.01 (+1.42%) ▲|PFE24.29+0.41 (+1.70%) ▲|PG150.62+3.19 (+2.16%) ▲|PLTR129.26+3.53 (+2.80%) ▲|PM180.70+3.01 (+1.69%) ▲|QCOM175.41-6.51 (-3.58%) ▼|RTX196.78+5.00 (+2.61%) ▲|SBUX105.31+1.92 (+1.86%) ▲|SCHW96.53+0.75 (+0.78%) ▲|SO96.50+1.38 (+1.45%) ▲|SPG224.55+1.55 (+0.69%) ▲|T20.05-0.44 (-2.12%) ▼|TMO526.53+13.20 (+2.57%) ▲|TMUS173.95+0.89 (+0.51%) ▲|TSLA399.63-25.67 (-6.04%) ▼|TXN294.77-3.64 (-1.22%) ▼|UBER73.75+1.09 (+1.50%) ▲|UNH428.35+1.81 (+0.42%) ▲|UNP280.80+3.07 (+1.11%) ▲|UPS110.40+0.86 (+0.79%) ▲|USB61.55-0.41 (-0.66%) ▼|V358.60+7.52 (+2.14%) ▲|VZ41.09-0.91 (-2.16%) ▼|WFC85.50-0.44 (-0.51%) ▼|WMT111.52+2.70 (+2.48%) ▲|XOM136.84+0.56 (+0.41%) ▲|
34.6 C
New York
Thursday, July 2, 2026

Tag: research

newssourceFORcompanyinformationcontent1releasesmarket

GenScript Biotech’s MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader

PISCATAWAY, N.J., July 31, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that...

Zenara Pharma Receives U.S. FDA Approval for First Generic of Sertraline Hydrochloride Capsules with 180-Day CGT Exclusivity

HYDERABAD, India, August 1, 2025 /PRNewswire/ -- Zenara Pharma Private Limited ("Zenara"), a Biophore company, today announced that it has received final approval from the U.S....

Zenara Pharma Receives U.S. FDA Approval for First Generic of Sertraline Hydrochloride Capsules with 180-Day CGT Exclusivity

HYDERABAD, India, July 31, 2025 /PRNewswire/ -- Zenara Pharma Private Limited ("Zenara"), a Biophore company, today announced that it has received final approval from the U.S....

New Force in Vaccine National Team: NHRI Spin-off ‘TaiU’ Completes US$2M Seed Round Led by MVL Seed Fund

TAIPEI, Aug. 1, 2025 /PRNewswire/ -- Taiwan Universe BioMedicine (TaiU), a startup spun off from the National Health Research Institutes (NHRI), today announced the completion...

Diamond Certified Preferred Membership Surpasses 175,000 Local Members

The always-free membership for those who love quality local companies reaches a new record. Members stand out when they use Diamond Certified companies and...

Newmark Arranges Sale of Trophy Dallas Office Tower, The Link at Uptown

Transaction is the Largest for an Office Property in Dallas Year-to-Date1 DALLAS, July 31, 2025 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or "the...

Evidence review suggests COVID-19 vaccines safe for pregnant women and their babies

WILLOW GROVE, Pa., July 31, 2025 /PRNewswire/ -- Pregnant women are at increased risk of illness due to infection compared with other adults, so...

Treatment Resistant Hypertension Market Set to Transform at a CAGR of 5% with Increasing Diagnosis and Treatment of Resistant Patients along with Approval and...

The treatment-resistant hypertension (TRH) market is expected to grow in the coming years due to the rising prevalence of uncontrolled hypertension and associated cardiovascular...

VedTechBio पेश करता है, नेक्स्ट जेन ड्रग डिस्कवरी एआई; मल्टीथेरेपी कोलेबोरेशन के तौर पर AlphaMeld के साथ साझेदारी में

BENGALURU, India, Aug. 01, 2025 (GLOBE NEWSWIRE) -- VedTechBio Research Pvt. Ltd., एआई-संचालित औषधि खोज में अग्रणी संगठन, ने आज अपने RxAgentAI™ प्लेटफॉर्म में प्रमुख संवर्द्धन की घोषणा की, जिससे औषधि खोज की समय-सीमा आधी रह गई, साथ ही मेटाबोलिक और दुर्लभ रोगों से संबंधित अनेक उपचारों के सह-विकास के लिए AlphaMeld Corporation के साथ रणनीतिक सहयोग भी किया गया।

FMC Corporation obtains registration in Great Britain for Fundatis® herbicide powered by Isoflex® active

PHILADELPHIA, July 31, 2025 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced it has received registration for Fundatis®...

RGC Resources, Inc. Schedules Third Quarter 2025 Earnings Call

ROANOKE, Va., July 31, 2025 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (Nasdaq: RGCO) will host its quarterly conference call and webcast to review the results of its fiscal third quarter 2025 on Wednesday, August 13, 2025 at 9:00 a.m. eastern time. Related presentation materials will be available before the call on the Company website on the Investor & Financial Information page at https://www.rgcresources.com/investor-financial-information/.

Huntsman Announces Second Quarter 2025 Earnings

Second Quarter Highlights Second quarter 2025 net loss attributable to Huntsman of $158 million compared to net income of $22 million in the prior year...

FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced second quarter 2025 financial results and provided a corporate update.

Healthcare Realty Reports Second Quarter 2025 Results

NASHVILLE, Tenn., July 31, 2025 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2025.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsResearch

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers